Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Epidermal growth factor receptor-tyrosine kinase inhibitors have improved progression-free survival and overall survival in non-small-cell lung cancer (NSCLC) patients with sensitive mutations. However, response of uncommon mutation to epidermal growth factor receptor-tyrosine kinase inhibitors is s...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Hua, Peng, Yanmei, Cui, Huijuan, Qiu, Yuqin, Li, Qiang, Zhang, Jingyi, Shen, Wen, Sun, Chenyao, Luo, Chufan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923252/
https://www.ncbi.nlm.nih.gov/pubmed/29731638
http://dx.doi.org/10.2147/OTT.S151125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923252/
https://www.ncbi.nlm.nih.gov/pubmed/29731638
http://dx.doi.org/10.2147/OTT.S151125

Ejemplares similares